Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus

Clinical Infectious Diseases

Volumn 33, Issue 9, 2001, Pages 1586-1594

  Paddock, Christopher D ^a   Folk, Scott M ^c,i   Shore, G Merrill ^d   Machado, Linda J ^e   Huycke, Mark M ^e   Slater, Leonard N ^e   Liddell, Allison M ^f   Buller, Richard S ^f   Storch, Gregory A ^f   Monson, Thomas P ^g   Rimland, David ^b   Sumner, John W ^a   Singleton, Joseph ^a   Bloch, Karen C ^h   Tang, Yi Wei ^h   Standaert, Steven M ^h,j   Childs, James E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Tallahassee Memorial Hospital   (United States)

^d St Vincents Medical Center   (Canada)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Heartland Health   (United States)

^j Infectious Disease Consultants   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL DNA; PROTEINASE INHIBITOR; RNA 16S; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIA EWINGII; EHRLICHIOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECREATION; SYMPTOM; TICK; UNITED STATES;

ADULT; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 0035503613     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323981     Document Type: Article

References (51)

1. Human infection with Ehrlichia canis, a leukocytic rickettsia
2. Human granulocytic ehrlichiosis in the upper midwest United States: A new species emerging?
3. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis
4. Brief report: Fatal seronegative ehrlichiosis in a patient with HIV infection
5. Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome
6. Identifying human ehrlichiosis
7. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis
8. Ehrlichia chaffeensis-associated cardiomyopathy in a patient with AIDS
9. Rapidly fatal infection with Ehrlichia chaffeensis
10. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis
11. Molecular cloning and characterization of the Ehrlichia chaffeensis variable length PCR target: An antigen-expressing gene that exhibits interstrain variation
12. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction
13. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: Clinical and molecular characteristics
14. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis
15. PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris
16. Human ehrlichiosis: Hematopathology and immunohistologic detection of Ehrlichia chaffeensis
17. Tissue diagnosis of Ehrlichia chaffeensis in patients with fatal ehrlichiosis by using in situ hybridization, immunohistochemistry, and polymerase chain reaction
18. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
19. Human ehrlichioses in the United States
20. Human ehrlichiosis in the United States, 1985 to 1990
21. Evidence for spread of the human immunodeficiency virus epidemic into low prevalence areas of the United States
22. Spread of AIDS in rural America, 1982-1990
23. Evidence of an increasing AIDS burden in rural America
24. Urbs in rure: Human immunodeficiency virus infection in rural Tennessee
25. The emerging epidemiology of rural AIDS
26. HIV seroprevalence across the rural/urban continuum
27. AIDS in rural eastern North Carolina-patient migration: A rural AIDS burden
28. The geography of AIDS: Patterns of urban and rural migration
29. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
30. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection
31. Human immunodeficiency virus-related opportunistic infections in the era of highly active antiretroviral therapy
32. Reliving a nightmare: A hard and tragic lesson in humility
33. Babesiosis in patients with AIDS: A chronic infection presenting as a fever of unknown origin
34. Human ehrlichiosis: Prospective active surveillance in febrile hospitalized patients
35. Human ehrlichiosis in adults after tick exposure
36. The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina
37. Human ehrlichiosis
38. Ehrlichiosis mimicking thrombotic thrombocytopenic purpura: Case report and pathological correlation
39. Human ehrlichiosis in a liver transplant recipient
40. Ehrlichia chaffeensis in a renal transplant recipient
41. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988
42. Lymphocytosis of γ/δ T cells in human ehrlichiosis
43. Serological evidence of possible human infection with Ehrlichia in Texas
44. Ehrlichial meningitis with cerebrospinal fluid morulae
45. Ehrlichiosis in a golf-oriented retirement community
46. Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations
47. Epidemiology of thrombocytopenia in HIV infection
48. Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole
49. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: Implications for surveillance